ArticleHaematologica2022

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience.

Ayalew Tefferi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.